Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Head Neck. 2016 Jul 28;38(12):1739–1751. doi: 10.1002/hed.24532

Figure 5.

Figure 5

Competing risk analysis for patients with T3 larynx cancer who underwent (a,d) larynx preservation with induction and/or concurrent chemoradiotherapy (LP-CRT), (b,e) larynx preservation with definitive radiotherapy alone (LP-RT), or (c,f) total laryngectomy followed by post-operative radiotherapy (TL-PORT).Patterns of failure are presented in the upper panels (a, b, and c); patterns of competing risk of demise by cause are presented in the lower panels (d, e, and f). Black dots represent aggregated data points and dashed lines represent confidence intervals.